Vaxinano

Vaxinano is a French biotech company developing nasal vaccines for infectious diseases. Its innovative, adjuvant-free platform offers high stability and ease of global distribution, addressing unmet needs in both human and animal health. The company's technology has shown efficacy against various pathogens across multiple species.

Buy Funded Startups lists

Funding Round:

Funding Amount: €6M

Date: 29-Oct-2024

Investors: TCD Capital, Captech Santé, Nord France Amorçage (NFA), Wiseed, a group of business angels, BPI France

Markets: Biotech, Vaccines, Therapeutics, Nanotechnology, Animal Health, Human Health

HQ: Loos, Hauts-de-France, France

Founded: 2016

Website: https://www.vaxinano.com/

LinkedIn: https://www.linkedin.com/company/vaxinano

Twitter: https://twitter.com/vaxinano

Instagram: